---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-032043"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T19:49:02.210195+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience Q3 revenue ex-license $235K, up 484% YoY; cash $0.3M, closes $0.35M debt

## Summary
- Revenue (ex-license) $235,321 (+484% YoY, +61% sequential); clinic revenue $176,395 (+370%), product sales $58,926 (+2,012%).
- Combined clinic revenue (consolidated + equity) $450,131 (+1,100% YoY, +111% sequential).
- Cash $0.3M at Sept 30; raised $0.35M in interim demand notes post-quarter; seeking additional funding.
- Adjusted EBITDA -$2.0M vs -$1.6M; gross margin 54% vs 49% adjusted prior year; no GAAP net income disclosed.
- Completed due diligence on clinic acquisition; Tampa INVO Center expected Q1 2023; updated 510(k) filed for 5-day incubation.

## SEC filing metadata
- accession: 0001493152-22-032043
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315222032043/0001493152-22-032043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315222032043/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-032043
- JSON: https://secwatch.observer/filing/0001493152-22-032043.json
- Plain text: https://secwatch.observer/filing/0001493152-22-032043.txt

## Key facts
- Earnings Releases
  INVO Fertility, Inc. reported the third quarter ended September 30, 2022 results: revenue $235,321.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $235,321
  - Result: reported results
  source text: Revenue for the three months ended September 30, 2022, was $235,321 compared to $218,874 for the three months ended September 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315222032043/0001493152-22-032043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.